TY - JOUR
T1 - IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection
AU - Moreno-Cubero, Elia
AU - Alrubayyi, Aljawharah
AU - Balint, Stefan
AU - Ogbe, Ane
AU - Gill, Upkar s.
AU - Matthews, Rebecca
AU - Kinloch, Sabine
AU - Burns, Fiona
AU - Rowland-Jones, Sarah l.
AU - Borrow, Persephone
AU - Schurich, Anna
AU - Dustin, Michael
AU - Peppa, Dimitra
N1 - Funding Information:
This work was supported by MRC grants MR/M008614 (to DP) and MR/K012037 (PB); NIH, NIAID, DAIDS UM1 grants AI00645 (Duke CHAVI-ID) and AI144371 (Duke CHAVD) (to PB), (R01AI55182) to DP, and R01 award AI147778 (to PB and DP); Academy of Medical Sciences Starter Grant (SGL021/1030), Seedcorn funding Rosetrees/Stoneygate Trust (A2903), and Mid-Career Research Award from The Medical Research Foundation (MRF-044-0004-F-GILL-C0823) (to USG); ERC AdG 670930 (to MLD and SB); and the Wellcome Trust 100262 (to MLD). SRJ and PB are Jenner Institute Investigators. We would like to thank Rafael J. Argüello for his assistance with the SCENITH assay. The graphical abstract and Supplemental Figure 1B were created with BioRender.com.
Publisher Copyright:
© 2024, Moreno-Cubero et al.
PY - 2024/2/22
Y1 - 2024/2/22
N2 - Dynamic regulation of cellular metabolism is important for maintaining homeostasis and can directly influence immune cell function and differentiation, including NK cell responses. Persistent HIV-1 infection leads to a state of chronic immune activation, NK cell subset redistribution, and progressive NK cell dysregulation. In this study, we examined the metabolic processes that characterize NK cell subsets in HIV-1 infection, including adaptive NK cell subpopulations expressing the activating receptor NKG2C, which expand during chronic infection. These adaptive NK cells exhibit an enhanced metabolic profile in HIV-1– individuals infected with human cytomegalovirus (HCMV). However, the bioenergetic advantage of adaptive CD57+NKG2C+ NK cells is diminished during chronic HIV-1 infection, where NK cells uniformly display reduced oxidative phosphorylation (OXPHOS). Defective OXPHOS was accompanied by increased mitochondrial depolarization, structural alterations, and increased DRP-1 levels promoting fission, suggesting that mitochondrial defects are restricting the metabolic plasticity of NK cell subsets in HIV-1 infection. The metabolic requirement for the NK cell response to receptor stimulation was alleviated upon IL-15 pretreatment, which enhanced mammalian target of rapamycin complex 1 (mTORC1) activity. IL-15 priming enhanced NK cell functionality to anti-CD16 stimulation in HIV-1 infection, representing an effective strategy for pharmacologically boosting NK cell responses.
AB - Dynamic regulation of cellular metabolism is important for maintaining homeostasis and can directly influence immune cell function and differentiation, including NK cell responses. Persistent HIV-1 infection leads to a state of chronic immune activation, NK cell subset redistribution, and progressive NK cell dysregulation. In this study, we examined the metabolic processes that characterize NK cell subsets in HIV-1 infection, including adaptive NK cell subpopulations expressing the activating receptor NKG2C, which expand during chronic infection. These adaptive NK cells exhibit an enhanced metabolic profile in HIV-1– individuals infected with human cytomegalovirus (HCMV). However, the bioenergetic advantage of adaptive CD57+NKG2C+ NK cells is diminished during chronic HIV-1 infection, where NK cells uniformly display reduced oxidative phosphorylation (OXPHOS). Defective OXPHOS was accompanied by increased mitochondrial depolarization, structural alterations, and increased DRP-1 levels promoting fission, suggesting that mitochondrial defects are restricting the metabolic plasticity of NK cell subsets in HIV-1 infection. The metabolic requirement for the NK cell response to receptor stimulation was alleviated upon IL-15 pretreatment, which enhanced mammalian target of rapamycin complex 1 (mTORC1) activity. IL-15 priming enhanced NK cell functionality to anti-CD16 stimulation in HIV-1 infection, representing an effective strategy for pharmacologically boosting NK cell responses.
UR - http://www.scopus.com/inward/record.url?scp=85185835051&partnerID=8YFLogxK
U2 - 10.1172/jci.insight.173099
DO - 10.1172/jci.insight.173099
M3 - Article
SN - 2379-3708
VL - 9
JO - JCI Insight
JF - JCI Insight
IS - 4
M1 - e173099
ER -